Cand5

Cand5 siRNA · OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Cand5, covering 2008-07-25 to 2008-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration [Phase 2]

See pricing